Risk Factors for the Acquisition of Nosocomial Infection with Carbapenem-Resistant Klebsiella pneumoniae

被引:65
作者
Wu, Dandan [1 ]
Cai, Jiachang [1 ]
Liu, Jin [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Infect Dis, Hangzhou 310009, Zhejiang, Peoples R China
关键词
carbapenem; Klebsiella pneumoniae; nosocomial infection; risk factor; HYDROLYZING BETA-LACTAMASE; NEW-YORK-CITY; PSEUDOMONAS-AERUGINOSA; HOSPITALIZED-PATIENTS; SERRATIA-MARCESCENS; CARE FACILITIES; KPC-2; EMERGENCE; IDENTIFICATION; ISOLATE;
D O I
10.1097/SMJ.0b013e318206063d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has been increasingly reported all over the world. In this study, we aimed to investigate the risk factors for the acquisition of nosocomial CRKP infections. Methods: We conducted a case-control study with data collected from thirty-nine patients with nosocomially acquired CRKP infection between July 2006 and July 2008. Controls were selected at a ratio of 1:2 from patients with nosocomial carbapenem-susceptible Klebsiella pneumoniae (CSKP) infection and were matched with CRKP cases for site of infection and the date of hospital admission (+/- within 5 days). T test, chi-square test, and logistic regression were used for statistical analysis. Results: Bivariable analysis showed that the age of the patients (P = 0.038), days of hospital stay prior to isolation of Klebsiella pneumoniae (K. pneumoniae) (P = 0.043), altered consciousness (P = 0.007), intensive care unit (ICU) admission within two weeks (P = 0.003), tracheal intubation (P = 0.027), mechanical ventilation (P = 0.009), number of changes in antibiotics >= 4 (P = 0.001), exposure to carbapenems (P = 0.002), exposure to fourth-generation cephalosporins (P = 0.027), and exposure to piperacillin-tazobactams/cefoperazone-sulbactams (P = 0.043) and glycopeptides (P = 0.042) were related to CRKP infection. The multivariable analysis showed that ICU admission (within two weeks) [odds ratio (OR): 4.68, 95% confidence intervals (CI): 1.15-19.09, P = 0.031], exposure to carbapenems (OR: 12.69, 95% CI: 2.09 77.10, P = 0.006) and exposure to glycopeptides (OR: 3.57, 95% CI: 1.11-11.42, P = 0.032) were independent risk factors for nosocomial CRKP infections. Conclusion: Several factors are related to CRKP infections. ICU admission (within two weeks) or prior exposure to carbapenems or glycopeptides are independent risk factors for the acquisition of nosocomial CRKP infections.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 29 条
[1]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60
[2]   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[3]   Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital [J].
Cai, Jia Chang ;
Zhou, Hong Wei ;
Zhang, Rong ;
Chen, Gong-Xiang .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2014-2018
[4]  
Cai Jia-Chang, 2008, Zhonghua Yi Xue Za Zhi, V88, P135
[5]  
Doménech-Sánchez A, 1999, J BACTERIOL, V181, P2726
[6]   Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study [J].
Falagas, Matthew E. ;
Rafailidis, Petros I. ;
Kofteridis, Diamantis ;
Virtzili, Simona ;
Chelvatzoglou, Fotini C. ;
Papaioannou, Vassiliki ;
Maraki, Sofia ;
Samonis, George ;
Michalopoulos, Argyris .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) :1124-1130
[7]   Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 [J].
Hidron, Alicia I. ;
Edwards, Jonathan R. ;
Patel, Jean ;
Horan, Teresa C. ;
Sievert, Dawn M. ;
Pollock, Daniel A. ;
Fridkin, Scott K. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (11) :996-1011
[8]   Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients [J].
Kwak, YG ;
Choi, SH ;
Choo, EJ ;
Chung, JW ;
Jeong, JY ;
Kim, NJ ;
Woo, JH ;
Ryu, J ;
Kim, YS .
MICROBIAL DRUG RESISTANCE, 2005, 11 (02) :165-169
[9]   Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae [J].
Landman, David ;
Bratu, Simona ;
Quale, John .
JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (10) :1303-1308
[10]   Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii:: a case-control study [J].
Lee, SO ;
Kim, NJ ;
Choi, SH ;
Kim, TH ;
Chung, JW ;
Woo, JH ;
Ryu, J ;
Kim, YS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :224-228